MX343653B - Síntesis de clorhidrato de metilfenidato a baja temperatura. - Google Patents

Síntesis de clorhidrato de metilfenidato a baja temperatura.

Info

Publication number
MX343653B
MX343653B MX2013007020A MX2013007020A MX343653B MX 343653 B MX343653 B MX 343653B MX 2013007020 A MX2013007020 A MX 2013007020A MX 2013007020 A MX2013007020 A MX 2013007020A MX 343653 B MX343653 B MX 343653B
Authority
MX
Mexico
Prior art keywords
low
methylphenidate hydrochloride
temperature synthesis
methylphenidate
hydrochloride
Prior art date
Application number
MX2013007020A
Other languages
English (en)
Other versions
MX2013007020A (es
Inventor
C Frederick M Huntley
Erik Wayne Kataisto
Lumiere Knicholaus Dudley La
Helge Alfred Reisch
Original Assignee
Rhodes Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhodes Tech filed Critical Rhodes Tech
Publication of MX2013007020A publication Critical patent/MX2013007020A/es
Publication of MX343653B publication Critical patent/MX343653B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención describe un proceso para la preparación de clorhidrato de metilfenidato. El proceso implica la esterificación del ácido ritalínico y metanol en presencia de un catalizador ácido a una baja temperatura. El proceso puede involucrar opcionalmente la adición de un ortoéster.
MX2013007020A 2010-12-17 2011-12-16 Síntesis de clorhidrato de metilfenidato a baja temperatura. MX343653B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201061424424P 2010-12-17 2010-12-17
PCT/IB2011/003140 WO2012080834A1 (en) 2010-12-17 2011-12-16 Low-temperature synthesis of methylphenidate hydrochloride

Publications (2)

Publication Number Publication Date
MX2013007020A MX2013007020A (es) 2014-11-10
MX343653B true MX343653B (es) 2016-11-07

Family

ID=45509554

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013007020A MX343653B (es) 2010-12-17 2011-12-16 Síntesis de clorhidrato de metilfenidato a baja temperatura.

Country Status (13)

Country Link
US (1) US9475770B2 (es)
EP (2) EP2937336A1 (es)
JP (1) JP5886869B2 (es)
KR (2) KR101561361B1 (es)
CN (1) CN103298785B (es)
AU (1) AU2011342894C1 (es)
BR (1) BR112013015072A2 (es)
CA (1) CA2822016C (es)
CO (1) CO6741202A2 (es)
ES (1) ES2542433T3 (es)
MX (1) MX343653B (es)
NZ (1) NZ612298A (es)
WO (1) WO2012080834A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014024203A1 (en) * 2012-08-07 2014-02-13 Zcl Chemicals Limited An improved process for - the preparation of dexmethylphenidate hydrochloride.
US9278928B2 (en) * 2012-11-29 2016-03-08 Zcl Chemicals Limited Process for the preparation of d-threo-ritalinic acid salts via novel salts of intermediate thereof
JP2016535751A (ja) * 2013-11-08 2016-11-17 ノランコ・インコーポレーテツドＮｏｒａｍｃｏ Ｉｎｃｏｒｐｏｒａｔｅｄ メチルフェニデート及びその製薬学的塩の調製プロセス
US20170196846A1 (en) * 2014-06-06 2017-07-13 Rhodes Pharmaceuticals, L.P. Methods for treating attention deficit hyperactivity disorder with methylphenidate
CA3018328A1 (en) 2014-10-31 2016-04-30 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
CN104744342A (zh) * 2015-02-11 2015-07-01 河南中帅医药科技股份有限公司 盐酸右哌甲酯晶型及其制备方法
CN107325039B (zh) * 2016-04-29 2022-12-16 国药集团国瑞药业有限公司 一种盐酸右哌甲酯的制备方法
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
CN110698341A (zh) * 2019-10-24 2020-01-17 安庆博曼生物技术有限公司 丙炔酸衍生物的环保制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2507631A (en) 1944-01-19 1950-05-16 Ciba Pharm Prod Inc Pyridine and piperidine compounds and process of making same
US2838519A (en) 1953-12-23 1958-06-10 Ciba Pharm Prod Inc Process for the conversion of stereoisomers
US2957880A (en) 1953-12-23 1960-10-25 Ciba Pharm Prod Inc Process for the conversion of stereoisomers
US4347374A (en) 1980-07-21 1982-08-31 Merck & Co., Inc. Acid addition salts of N-trityl-α-fluoromethylhistidine enantiomer derivatives
US5733756A (en) 1996-01-05 1998-03-31 Celgene Corporation Lactams and processes for stereoselective enrichment of lactams, amides, and esters
US6242464B1 (en) 1996-01-22 2001-06-05 Chiroscience Limited Single isomer methylphenidate and resolution process
GB9604943D0 (en) 1996-03-08 1996-05-08 Chiroscience Ltd Resolution
HUP0001604A3 (en) 1996-12-13 2003-03-28 Medeva Europ Ltd The preparation of an enantiomerically-enriched threo-methylphenidate
GB9700912D0 (en) * 1997-01-17 1997-03-05 Chiroscience Ltd Resolution
US5936091A (en) 1997-05-22 1999-08-10 Celgene Corporation Processes and intermediates for resolving piperidyl acetamide stereoisomers
US6548522B1 (en) 1999-10-12 2003-04-15 Hoffmann-La Roche Inc. Method for treating conditions related to the glutamate receptor using carboxylic acid amide derivatives
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
WO2004067516A1 (en) 2003-01-30 2004-08-12 Boehringer Ingelheim Pharmaceuticals, Inc. 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta
CH712083B1 (de) 2003-02-05 2017-07-31 Siegfried Ag Verfahren zur Herstellung von d-threo-2-Phenyl-2-piperidin-2-yl-essigsäureestern.
US20050032873A1 (en) 2003-07-30 2005-02-10 Wyeth 3-Amino chroman and 2-amino tetralin derivatives
US7229557B2 (en) 2004-02-04 2007-06-12 Konec, Inc. Method to separate stereoisomers
US20100209345A1 (en) 2006-08-24 2010-08-19 Australian Nuclear Science & Technology Organisation Fluorinated Ligands for Targeting Peripheral Benzodiazepine Receptors
WO2008087190A2 (en) 2007-01-18 2008-07-24 Novo Nordisk A/S Use of peptides in combination with surgical intervention for the treatment of obesity
WO2010080787A1 (en) 2009-01-09 2010-07-15 Mallinckrodt Inc. Synthesis of methylphenidate and analogs thereof
ES2465219T3 (es) * 2009-12-01 2014-06-05 Harman Finochem Limited Proceso para la preparación de clorhidrato de metilfenidato

Also Published As

Publication number Publication date
KR101561361B1 (ko) 2015-10-16
US9475770B2 (en) 2016-10-25
CA2822016C (en) 2016-10-25
ES2542433T3 (es) 2015-08-05
EP2651892B1 (en) 2015-04-22
AU2011342894C1 (en) 2015-07-30
NZ612298A (en) 2014-06-27
JP5886869B2 (ja) 2016-03-16
WO2012080834A1 (en) 2012-06-21
CN103298785A (zh) 2013-09-11
EP2937336A1 (en) 2015-10-28
US20150038720A1 (en) 2015-02-05
KR20130115322A (ko) 2013-10-21
JP2014503530A (ja) 2014-02-13
EP2651892A1 (en) 2013-10-23
KR20150029769A (ko) 2015-03-18
WO2012080834A8 (en) 2012-09-13
MX2013007020A (es) 2014-11-10
BR112013015072A2 (pt) 2016-07-12
CA2822016A1 (en) 2012-06-21
AU2011342894B2 (en) 2015-05-07
CN103298785B (zh) 2016-04-20
AU2011342894A1 (en) 2013-05-02
CO6741202A2 (es) 2013-08-30

Similar Documents

Publication Publication Date Title
MX343653B (es) Síntesis de clorhidrato de metilfenidato a baja temperatura.
EG27127A (en) Process for producing ammonia synthesis gas
ZA201302642B (en) Method for producing acrylic acid from methanol and acetic acid
ZA201500367B (en) Process and reaction system for the preparation of methanol
EP2653458A4 (en) PROCESS FOR PREPARING ACETIC ACID
ZA201404090B (en) Process for producing reforming catalyst and reforming of methane
MX2013009175A (es) Composiciones que comprenden acido peroxi alfa-cetocarboxilico y metodos para producirlas y usarlas.
EP2616173A4 (en) METHOD FOR PRODUCING A CARBON-CONTAINING SUPPORT
AP2012006428A0 (en) Process for the synthesis of methanol
EP2578313A4 (en) Solid base catalyst
EP2514526A4 (en) HYDROGEN COMBUSTION CATALYST AND METHOD OF MANUFACTURING THEREOF, AND HYDROGEN CURING METHOD
PL2576628T3 (pl) Sposób wytwarzania celulozy mikrokrystalicznej
EP2650376A4 (en) PROCESS FOR THE PREPARATION OF L-AMINO ACID
EP2542338A4 (en) Catalysts for feedstock-flexible and process-flexible hydrogen production
EP2810711A4 (en) DEHYDRATION CATALYST FOR AMERICO ACID, METHOD FOR THE PRODUCTION OF HYDROGEN AND METHOD FOR THE PRODUCTION OF DEUTERIUM GAS OR DEUTERATED HYDROGEN
EP2731712A4 (en) CATALYST AND REFORMING METHOD
IL224318B (en) A method for the automated synthesis of small molecules
ZA201206246B (en) Method for producing synthesis gas
DK2650049T3 (da) Hydrogenbehandlingskatalysator og fremgangsmåde til fremstilling af denne
ZA201208672B (en) Process for the preparation of synthesis gas
PL2588439T3 (pl) Sposób wytwarzania kwasu mrówkowego drogą reakcji ditlenku węgla z wodorem
PL2533808T3 (pl) Sposób produkcji oczyszczonego ekstraktu z alergenu
EP2561927A4 (en) PRODUCTION PROCESS FOR CATALYST
EP2595225A4 (en) METHOD FOR PRODUCING A FUEL CELL CATALYST, FUEL CELL CATALYST AND USE THEREOF
EP2551256A4 (en) PROCESS FOR THE PRODUCTION OF SUCCINIC ACID

Legal Events

Date Code Title Description
FG Grant or registration